This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 60-minute on-demand session from the ASAM 56th Annual Conference addresses strategies and system-level changes to better engage the 95% of individuals with substance use disorders who are not currently accessing or interested in services.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the current research evidence surrounding the screening, diagnosis, and treatment of technology-associated behavioral addictions."

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses national trends in SUD and treatment engagement and local examples of implementation challenges, and outlining potential strategies such as creating trauma-sensitive, nonjudgmental environments, supporting patient engagement across the continuum of care, and avoiding administrative discharges for patients who return to use during treatment.

This one-hour, on-demand, journal article-based activity examines the risks associated with pregnancy and elective termination among females receiving treatment for substance use disorder (SUD) compared to those not in treatment.

This one-hour, on-demand, journal article-based activity discusses non-invasive neuromodulation techniques for alcohol use disorder (AUD).

The ASAM Motivational Interviewing (MI) Essentials is a 4-hour online course designed for clinicians to practice skills that are consistent with motivational interviewer behaviors and to reflect on how to employ these skills in their clinical settings.

This one-hour course equips healthcare professionals with practical strategies to navigate the complex challenges of buprenorphine prescribing for opioid use disorder (OUD) in both hospital and clinic settings.

This one-hour, on-demand, journal article-based activity examines a retrospective single-center cohort study of the predictors of AUD treatment among inpatients with alcohol-associated liver disease. A brief intervention on AUD had the strongest association with receiving AUD treatment in our cohort. Further efforts to incorporate brief interventions when offering AUD treatment to patients with ALD may be beneficial.

This four-episode podcast series focused on improving hospital and clinic-based buprenorphine treatment for OUD provides experts insights, practical strategies, and real-world approaches to overcoming common challenges.